The estimated Net Worth of Michael E Prevoznik is at least $20.9 Milhão dollars as of 29 August 2024. Mr. Prevoznik owns over 32,551 units of Quest Diagnostics stock worth over $10,907,213 and over the last 21 years he sold DGX stock worth over $7,880,144. In addition, he makes $2,090,390 as Senior Vice President e General Counsel at Quest Diagnostics.
Michael has made over 51 trades of the Quest Diagnostics stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 32,551 units of DGX stock worth $3,118,386 on 29 August 2024.
The largest trade he's ever made was exercising 126,667 units of Quest Diagnostics stock on 17 June 2013 worth over $5,767,149. On average, Michael trades about 8,719 units every 51 days since 2004. As of 29 August 2024 he still owns at least 71,029 units of Quest Diagnostics stock.
You can see the complete history of Mr. Prevoznik stock trades at the bottom of the page.
Michael E. Prevoznik serves as Senior Vice President, General Counsel of the Company. Mr. Prevoznik joined the Company as Vice President and General Counsel in August 1999. In 2003, he assumed responsibility for governmental affairs. From 1999 until April 2009, Mr. Prevoznik also had responsibility for the Company's Compliance Department. In addition, from April 2011 to January 2017, he had management responsibility for the Company's diagnostic information services activities outside the U.S., and from April 2011 to January 2013, he had management responsibility for the Company's clinical trials business. Prior to joining the Company, Mr. Prevoznik served in positions of increasing responsibility within the compliance organization at SmithKline Beecham, most recently as Vice President, Compliance, with responsibility for coordinating all SmithKline Beecham compliance activities worldwide.
As the Senior Vice President e General Counsel of Quest Diagnostics, the total compensation of Michael Prevoznik at Quest Diagnostics is $2,090,390. There are 7 executives at Quest Diagnostics getting paid more, with Stephen Rusckowski having the highest compensation of $10,118,500.
Michael Prevoznik is 58, he's been the Senior Vice President e General Counsel of Quest Diagnostics since 2003. There are 11 older and 8 younger executives at Quest Diagnostics. The oldest executive at Quest Diagnostics, Inc. is Gail Wilensky, 76, who is the Independent Director.
Over the last 21 years, insiders at Quest Diagnostics have traded over $67,426,608 worth of Quest Diagnostics stock and bought 34,000 units worth $1,910,090 . The most active insiders traders include Plc Gsk, James F Iii Flaherty, eJeffrey M Leiden. On average, Quest Diagnostics executives and independent directors trade stock every 19 days with the average trade being worth of $3,750,703. The most recent stock trade was executed by Michael E Prevoznik on 29 August 2024, trading 32,551 units of DGX stock currently worth $3,118,386.
quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator
Quest Diagnostics executives and other stock owners filed with the SEC include: